Calbade™ 667 Each Tablets contains Calcium acetate 667 mg, acts as a phosphate binder.
- Calbade™ 667 Tablets are administered orally for the control of Hyperphosphatemia in end-stage renal failure.
- Calbade™ 667 is used to prevent high blood phosphatelevels in patients who are on dialysis due to severe kidney disease.
Decreasing blood phosphate levels can help keep your bones strong, Prevent unsafe buildup of minerals in your body, and possibly decrease the risk of heart disease and strokes that can result from high phosphate Levels.
![Calbade 2](http://aubadehealthcare.com/wp-content/uploads/2022/06/Calbade-2.jpg)
Mechanism of Action
Calbade™ 667 tablet, when taken with meals, combines with dietary phosphate to form an insoluble calcium phosphate complex, which is excreted in the feces, resulting in decreased Serum phosphorus concentration
Dosage:
As directed by the physician..
Indication:
- Hyperphosphatemia
Adverse effects:
- Increased calcium in the blood
- Diarrhea
- Nausea